Supreme Court Temporarily Restores Abortion Pill Mail Access

Earlier this week, the US Supreme Court issued a temporary stay that reinstates mail access to mifepristone, the most commonly used abortion pill in the country. The order pauses recent lower court decisions that had imposed strict limits on telehealth prescriptions and mail delivery of the medication, effective immediately while legal challenges play out.

What Does the Supreme Court’s Order Do?

The high court’s unsigned order blocks a ruling from the 5th US Circuit Court of Appeals that would have required patients to pick up mifepristone in person from a certified clinic or doctor, even in states where abortion remains legal.

It also reverses a Texas district court decision that sought to revoke the FDA’s 2021 rule allowing mifepristone to be mailed to patients after a telehealth consultation.

For now, patients can once again receive mifepristone via mail after a virtual appointment with a licensed provider, a practice that expanded during the COVID-19 pandemic and has been widely used by people in rural areas or states with limited abortion access.

Why Was Mail Access to the Abortion Pill Restricted?

The legal battle stems from a lawsuit filed by anti-abortion groups in 2022, shortly after the Supreme Court overturned Roe v. Wade. The groups argued the FDA had improperly approved mifepristone and later eased access to the pill without sufficient safety review.

Lower courts sided with the plaintiffs in part, issuing rulings that would have:

• Banned mailing of mifepristone to patients in all 50 states
• Required in-person dispensing of the medication, even for patients in states with protected abortion rights
• Reinstated pre-2021 rules that required three in-person doctor visits to access the pill

The Biden administration and major medical groups, including the American Medical Association, argued these restrictions would create unnecessary barriers to safe, legal abortion care, particularly for low-income people and those living in rural areas.

What’s Next for Mifepristone Access?

The Supreme Court’s order is temporary, meaning the underlying legal case will continue to move through the lower courts. The 5th Circuit is set to hear additional arguments in the coming months, with a potential final Supreme Court ruling on the medication’s long-term access possible as early as 2024.

Legal experts note the high court’s decision to issue a stay suggests a majority of justices are skeptical of the lower court’s broad restrictions, but the temporary nature of the order leaves room for future changes.

Key Takeaways for Patients and Providers

If you’re seeking abortion care or prescribing mifepristone, here’s what you need to know right now:

• Mail delivery of mifepristone is legal and available in all states as of the Supreme Court’s order
• Telehealth appointments for the pill are once again permitted under FDA rules
• Patients in states with abortion bans are still subject to local laws, even with mail access restored
• Providers can resume mailing the medication to eligible patients immediately

Expert Reactions to the Ruling

Reproductive health advocates praised the order as a critical win for abortion access. "This temporary relief ensures millions of people can still access safe, effective abortion care without having to navigate impossible logistical barriers," said Alexis McGill Johnson, president of Planned Parenthood Federation of America.

Anti-abortion groups, meanwhile, criticized the decision, arguing the FDA’s relaxed mifepristone rules put patients at risk. "We will continue to fight to restore common-sense safety standards for this drug," said a spokesperson for the Alliance Defending Freedom, which represented the plaintiffs in the lawsuit.

What This Means for Abortion Access Moving Forward

The Supreme Court’s temporary order offers a reprieve for abortion providers and patients alike, but the long-term future of mifepristone access remains uncertain. As legal battles continue, advocates urge patients to stay informed about local laws and access resources like the National Abortion Federation hotline for up-to-date care options.

For now, mail access to the abortion pill is back — a small but significant win for reproductive rights supporters, even as the fight over mifepristone’s future continues in the courts.